NovelStem International Corp’s mission to revolutionize cancer treatment is promising, but its financial instability and lack of profitability raise concerns about its long-term viability.

NovelStem International Corp is pioneering a new approach to cancer treatment by developing diagnostic technologies that predict chemotherapy resistance, potentially leading to more targeted and effective treatments.